ICSE Zone at CPhI North America
A Showcase of Contract Services Spanning the Pharma Supply Chain
Home to 25% of the world’s pharmaceutical contract research and manufacturing, North America owns the largest market share of these vital services.
And there’s no better place to tap into this critical mega pharma segment than the ICSE Drug Development Zone—the largest global stage for companies providing contract services in all the key areas you’re looking to expand: Clinical trials, Contract research, Contract manufacturing, Biotech, IT, Analytical services, Packaging services, Logistics...
Global market for pharmaceutical contract research and manufacturing services set to grow by an average of 13.6% annually.
North America is home to the largest share of the pharmaceutical contract research and manufacturing services market with 24.9% being based there. The CRO market is expected to reach $45.2bn by 2022.
The global clinical trials market is projected to reach around $22 billion by the year 2021.
Successful CMO’s will need to have flexible business models and differentiated capacity to act even more as solution providers than ever before.
